Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates.

Financials

Total raised
$54k
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2015 $54k Details